Secondary |
Product Used For Unknown Indication |
30.1% |
Urticaria |
12.1% |
Pruritus |
7.7% |
Pharyngitis |
5.5% |
Faecaloma |
5.1% |
Liver Transplant |
4.4% |
Drug Use For Unknown Indication |
4.0% |
Acute Sinusitis |
3.7% |
Ischaemic Cardiomyopathy |
3.7% |
Asthma |
3.3% |
Lung Neoplasm Malignant |
3.3% |
Psoriasis |
2.2% |
Rheumatoid Arthritis |
2.2% |
Rhinitis Allergic |
2.2% |
Vomiting |
2.2% |
Breast Cancer |
1.8% |
Gastritis Prophylaxis |
1.8% |
Self Injurious Behaviour |
1.8% |
Leukocytoclastic Vasculitis |
1.5% |
Ill-defined Disorder |
1.1% |
|
Urticaria |
13.3% |
Somnolence |
8.9% |
Cerebral Haemorrhage |
6.7% |
Fatigue |
6.7% |
Urticaria Chronic |
6.7% |
Visual Acuity Reduced |
6.7% |
Drug Ineffective |
4.4% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.4% |
Dyspnoea |
4.4% |
Hepatitis Fulminant |
4.4% |
Pain In Extremity |
4.4% |
Pulmonary Hypertension |
4.4% |
Rhabdomyolysis |
4.4% |
Vomiting |
4.4% |
Weight Decreased |
4.4% |
Aspartate Aminotransferase Increased |
2.2% |
Asthenia |
2.2% |
Atrial Fibrillation |
2.2% |
Cardio-respiratory Arrest |
2.2% |
Childhood Depression |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
18.4% |
Drug Use For Unknown Indication |
14.4% |
Asthma |
9.1% |
Prophylaxis |
8.0% |
Hypertension |
7.7% |
Psoriasis |
6.3% |
Rheumatoid Arthritis |
4.2% |
Hypersensitivity |
3.8% |
Cough |
3.0% |
Constipation |
2.9% |
Hepatitis C |
2.7% |
Multiple Myeloma |
2.6% |
Insomnia |
2.3% |
Gastritis |
2.3% |
Analgesic Therapy |
2.2% |
Cystitis |
2.2% |
Periodontitis |
2.2% |
Seasonal Allergy |
2.1% |
Depression |
2.0% |
Pruritus |
1.7% |
|
Osteomyelitis |
10.8% |
Pyrexia |
8.1% |
Liver Disorder |
7.2% |
Cerebral Infarction |
6.3% |
Pharyngeal Oedema |
5.4% |
Rash |
5.4% |
Toxic Skin Eruption |
5.4% |
Vasculitis |
5.4% |
Vomiting |
5.4% |
Drug Eruption |
4.5% |
Urticaria |
4.5% |
Allergic Granulomatous Angiitis |
3.6% |
Bronchitis |
3.6% |
Lung Disorder |
3.6% |
Pneumonia |
3.6% |
Pruritus |
3.6% |
Stomatitis |
3.6% |
Thrombocytopenia |
3.6% |
Tremor |
3.6% |
Asthma |
2.7% |
|
Interacting |
Drug Use For Unknown Indication |
44.4% |
Bronchitis |
22.2% |
Rhinitis |
22.2% |
Hypersensitivity |
5.6% |
Hypertension |
5.6% |
|
Drug Interaction |
66.7% |
Renal Failure Acute |
33.3% |
|